Surgical treatment of late metastases of kidney cancer
Surgical treatment of late metastases of kidney cancer
复制标题
肾癌晚期转移的手术治疗
DOI：
--
复制
发表时间：
1999
期刊：
影响因子：
--
通讯作者：
Began
中科院分区：
文献类型：
--
作者：
Matveev Vb;Gurariĭ Ll;Began
：虽然 25-57% 诊断为肾细胞癌 (RCC) 的患者存在转移性疾病，但约 50% 的 (RCC) 患者在可能治愈的根治性肾切除术后出现转移。手术切除孤立性转移瘤后的五年生存率约为 35-50%。我们的经验表明，一小群患者受益于积极的手术治疗，以治疗随后出现的孤立性远处转移，并获得长期姑息治疗。
: Whereas 25-57% of patients diagnosed with renal cell carcinoma (RCC) present with metastatic disease, about 50% of (RCC) patients develop metastases after potentially curative radical nephrectomy. Five-year survival at following surgical removal of solitary metastases is approximately 35-50%. Our experience demonstrate that a small cohort of patients benefit from aggressive surgical therapy for consequtively arising solitary distant metastases with long-term palliation.